Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

It should not have taken a pandemic to highlight BAME health inequalities

Disproportionate impact of COVID-19 on BAME populations not explained by cardiometabolic factors, vitamin D or deprivation, researchers findSubscription

Variations in cardiometabolic factors, vitamin D levels and socioeconomic or behavioural factors do not adequately explain why COVID-19 disproportionately affects black, Asian and minority ethnic populations.

Old man with IBD

Inflammatory bowel disease may be linked to increased risk of dementiaSubscription

People with inflammatory bowel disease have a significantly higher risk of developing dementia later in life, a study in Gut has suggested.

Secukinumab and adalimumab comparable for first-line psoriatic arthritis treatment

Secukinumab and adalimumab comparable for first-line psoriatic arthritis treatmentSubscription

Biological therapies secukinumab and adalimumab are similarly effective at improving the musculoskeletal symptoms of psoriatic arthritis, a head-to-head trial suggests.

medication overuse headache

Withdrawal and preventive therapy best management for medication overuse headacheSubscription

Medication overuse headache is best treated with a combination of analgesic withdrawal and pharmaceutical prophylaxis, the authors of a study in JAMA Neurology have said.

Fingerprick test ss20

SGLT2 inhibitors linked to reduced risk of serious renal eventsSubscription

Sodium-glucose co-transporter 2 inhibitors are associated with a lower incidence of serious renal events in people with diabetes, a study in the BMJ has suggested.

Remdesivir bottles

No significant efficacy difference between courses of remdesivir in patients with severe COVID-19

There is no significant difference in efficacy between five-day and ten-day courses of the antiviral remdesivir for patients with severe COVID-19 not requiring ventilation, research published in The New England Journal of Medicine has shown.

Patient in critical care in hospital

Corticosteroids should be used with caution in patients with COVID-19, researchers say

The use of corticosteroids in coronavirus infections is associated with increased risk of death and side effects, such as bacterial infections and hypokalaemia, researchers have said.

Chinese woman having blood pressure taken

Renin-angiotensin system inhibitors not linked to COVID-19 severity, researchers conclude

Among people with hypertension, the severity of COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, data from Wuhan, China, suggest.

MDT meeting

Daily multidisciplinary team meetings could cut COPD hospital staysSubscription

Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.

More research briefings

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs